cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who have been pathologically or clinically diagnosed as malignant tumors and are scheduled to receive the LBP regimen; 2) Completely follow the real medical procedures, and evaluate the patient's age, gender, comorbidities, primary tumor type,Pathological types, clinical stages, number of chemotherapy lines, chemotherapy regimens and chemotherapy methods were not uniformly prescribed.
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating women, women who were preparing for pregnancy within 6 months before enrollment; 2) Subjects who have participated in investigational drug/device clinical trials within 4 weeks before enrollment; 3) For other reasons, the researcher considers it unsuitable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Characteristics of users;Clinical characteristics of drug use;Quality of life changes before and after treatment; | — |
Countries
China
Contacts
Chongqing University Cancer Hospital